Lupin gets FDA approval of sNDA for Solosec
The supplemental adolescent approval enhances Solosec's strong position as the first and only single-dose oral prescription…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Solosec
Lupin inks pact with Exeltis to promote Solosec drug in US
As part of the tie-up, Exeltis will promote Solosec along with its existing line of women's health products
Lupin gets USFDA approval of sNDA for SOLOSEC (secnidazole) to treat trichomoniasis
SOLOSEC demonstrated a 92.2 per cent clinically and statistically significant cure rate for patients with trichomoniasis based on…
Lupin presents Phase 3 data for Solosec in female patients with trichomoniasis
The company plans to submit a supplemental New Drug Application for Solosec to the FDA for the treatment of trichomoniasis later…
Lupin aims to launch new products across geographies this fiscal
"Looking ahead, FY2020 is an exciting year for Lupin as we plan to bring our first biosimilar to market and commercialise our…